4Teen4 Pharmaceuticals GmbH

https://www.4teen4.de

4TEEN4 Pharmaceuticals GmbH is a company with a clear mission: Improving the management of critically ill patients, which suffer from diseases related to massive cell death and thus uncontrolled Dipeptidyl peptidase 3 (DPP3) release into the bloodstream. Based on data that prove the reliability of DPP3 as a marker associated with short-term patient outcome, we identified DPP3 as a druggable target. The long-term vision is to provide a therapeutic solution for critically ill patients that neutralizes circulating DPP3 in order to restore proper organ function and improve survival. To achieve this mission, we develop monoclonal antibody therapies accompanied by a targeted diagnostic. Our lead product is a first-in-class drug candidate, the humanized monoclonal antibody Procizumab, accompanied by different diagnostics. The 4TEEN4 Pharmaceuticals GmbH, former Sphingotec Therapeutics GmbH, was established in 2013 and is managed by Andreas Bergmann, Ph.D.. The company is located in Hennigsdorf near Berlin, Germany. The diagnostic assay measures DPP3 concentrations in the blood, assessing the risk of short-term organ dysfunction and mortality. The antibody therapy neutralizes DPP3 in the blood, rescuing organ function. *

	Start	2019-07-03 renamed
	Predecessor	SphingoTec Therapeutics GmbH
	Industry	cardiovascular drug
	Industry 2	procizumab
	Person	Bergmann, Andreas (Sphingotec GmbH 201301 Managing Director)

	Region	Hennigsdorf
	Country	Germany
	Street	15A Neuendorfstr.
	City	16761 Hennigsdorf
		Address record changed: 2020-12-02

Basic data	Employees	A: 1 to 10 (2017-09-07)

		�About Section� taken from web site of organisation on 06.12.

		Record changed: 2023-12-30

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for 4Teen4 Pharmaceuticals GmbH

[1] 4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]